Navigation Links
Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth
Date:10/5/2010

WORCESTER, Mass,, Oct. 5 /PRNewswire/ -- Generex Biotechnology Corporation (Nasdaq: GNBT) (www.generex.com) announced today a corporate update in a letter to shareholders from Interim President and Chief Executive Officer, Mark Fletcher, addressing management's strategic initiatives for growth. The letter to shareholders reads as follows:

Since I've taken the position of CEO at Generex, the management team has been working diligently to refine its comprehensive plan for the advancement of our current proprietary drug delivery and immunotherapeutic vaccine platforms as well as the Company's strategic vision for future growth.  Over the past twelve months, we have seen significant advancements in both of our platform technologies and we are encouraged by our progress.

Since Generex Oral-lyn™, our proprietary buccal insulin spray product, has been the main focus by many audiences following our Company, I will begin by providing a synopsis of that program as well as providing our vision for the future of this important buccal drug delivery platform.  I would, however, like to emphasize that when evaluating our Company, one should not overlook the tremendous potential of our immunotherapeutic vaccine technologies which I will also address here in greater detail.

We are currently in an ongoing Phase III clinical trial of Generex Oral-lyn™ and have reported preliminary outcomes and trends in June of this year suggesting a better "Adverse Event" profile than subjects using injectable insulin as well as no weight gain.   In fiscal 2010, the safety and efficacy profile of Generex Oral-lyn™ led the Food and Drug Administration (FDA) to grant us approval for the treatment use of Generex Oral-lyn™ in patients with Type 1 or Type 2 diabetes mellitus under the FDA's "Treatment IND" program and later i
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... CHAPEL HILL, N.C. , March 27, 2015 /PRNewswire/ ... function is essential to meeting challenges in clinical development, ... and face tighter regulations, the Medical Affairs function is ... charted by mature markets. According to ... market study participants have a group dedicated to Medical ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 ... of Ohr Pharmaceutical, Inc. (NASDAQ: OHRP ) concerning ... certain statements issued by the Company in connection with ... information, GO TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact ... jlevi@zlk.com or by telephone at (212) 363-7500, ...
(Date:3/27/2015)... , March 27, 2015 Dynatronics Corporation (NASDAQ: ... has been appointed to the Company,s Board of Directors ... the death in November 2014 of board member Joseph ... Linder to our Board of Directors represents an important ... , chairman and president of Dynatronics.  "Rich is a proven ...
Breaking Medicine Technology:Medical Affairs Capabilities Expanding in Emerging Marketplaces 2Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2
... HUNTSVILLE, Ala., Dec. 13, 2010 EGEN, Inc. today announced ... the treatment of recurrent ovarian cancer is now open for ... (GOG) under an agreement between the GOG and EGEN, Inc., ... by the GOG at member institutions.  The University of Alabama ...
... ), a leading patent broker, today announced the successful closing ... were offered to companies that participate in the relevant markets ...  After announcing the auction date on Tuesday Dec. 7, iLeverage ... companies. "We met with leaders of the medical ...
Cached Medicine Technology:EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment 2EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment 3
(Date:3/27/2015)... 2015 In her mid-forties and with a ... working, Monica K. arrived at JET Uniform & Supply ... defensive and scared. The owners and staff at JET, which ... (EPSS) to offer jobs to challenged residents like Monica, were ... willingness to begin with the end in mind,” says Stephen ...
(Date:3/27/2015)... March 27, 2015 Top medical tourism ... patients travel to the Dominican Republic to benefit from ... clinic is turning the medical tourism industry upside-down and ... — with trustworthy services becoming the central influence. ... plastic surgeon. Patients are not only attracted to low-cost ...
(Date:3/27/2015)... 2015 While deep learning was the topic ... conference (GTC) , the CEO of one start-up spoke passionately ... human lifespan well beyond the generally-agreed ceiling of 120 years. ... is one of 12 companies recognized as the hottest GPU-powered ... the GTC Emerging Companies Summit have business models ...
(Date:3/27/2015)... 2015 Endure Yoga is launching WOD ... athletes. This new program matches yoga poses with functional ... cool down. This program utilizes yoga to improve recovery, ... focus. , Karen Lefurgy, competitive athlete at ... before I started Crossfit® training, but quickly, due to ...
(Date:3/27/2015)... March 27, 2015 GrassrootsHealth, an international ... Our Children (POC) NOW! vitamin D demonstration project April ... of South Carolina (MUSC), and will soon follow with ... at no cost to a minimum of 500 pregnant ... within these two service areas. The project will include ...
Breaking Medicine News(10 mins):Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4
... influence over everyday life, emotional support, and cultural and ... stress. Those were the results of a dissertation from ... and worry amongst teenagers have increased markedly in recent ... the WHO, as many as seven out of ten ...
... for better food choices for kids , , WASHINGTON, ... dive into the pool, head to the park, and grab ... may also leave nutrition behind; nutrition essential to fuel the ... expert Chere Bork, a registered dietitian with more than 30 ...
... 23 Today the 400,000-strong seniors group RetireSafe ... (PhRMA) for its commitment to support legislation to ... seniors who fall into the Medicare Part D ... called the commitment, "a huge gift to older ...
... New research which suggests a direct link between smoking and ... the Journal of Neurochemistry . Researchers, led by Debapriya ... Research Center (NBRC), have found that a compound in tobacco ... attack healthy cells, leading to severe neurological damage. ...
... , WASHINGTON DC, June 23 ... Anglo American, has been recognised by the,Global Business Coalition ... program focused on tackling HIV and AIDS in South,Africa. ... over 100,000 people employed at its operations. , ...
... Helix BioPharma Corp. (TSX, FSE: HBP; OTCQX: HXBPF) announced today ... OTCQX International Market under the ticker symbol HXBPF. Investors ... OTCQX International Market at www.otcqx.com . , ... access to the largest capital market in the world," said ...
Cached Medicine News:Health News:How adolescent girls manage stress 2Health News:Summer is Here! Top Five Tips for Making Your Child's Summer Eating Habits Healthier 2Health News:New research discovers link between smoking and brain damage 2Health News:Anglo American's Coal Division in South Africa Wins Global Business Coalition Award for top International Workplace HIV and AIDS Programme 2Health News:Anglo American's Coal Division in South Africa Wins Global Business Coalition Award for top International Workplace HIV and AIDS Programme 3Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 2Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 3Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 4
Stryker's 40-liter insufflator provides superior performance with unprecedented safety and reliability....
Bipolar forceps...
... INFORM HPV allows the pathologist to visualize the ... allows testing on a choice of sample types: ... HPV cocktails utilize proprietary probe formulations. The Family ... genotypes 16, 18, 31, 33, 35, 39, 51, ...
... Common primary human fungal pathogens ... spp., opportunistic fungal pathogens, including ... cerevisiae, Acremonium, Coccidioides immitis, Histoplasma ... and Pneumocystis carinii. The (1-3)--D-glucan ...
Medicine Products: